Dr. Michael Megaly Invited as Faculty at CRT 2024 to Address Mechanical Circulatory Support in Complex High-Risk PCI

March 2024 | Washington, DC

Cardiovascular Research Technologies (CRT) is one of interventional cardiology's most prestigious annual meetings; a gathering where the field's top operators present, debate, and define best practices.

In March 2024, Dr. Michael Megaly was invited as faculty to present on one of the most consequential decisions in complex PCI: when and how to use mechanical circulatory support (MCS).

Why This Talk Matters

Not every high-risk PCI patient needs MCS. But without it, for the wrong patient, the consequences can be catastrophic. Getting this decision right, before the first wire crosses a lesion, separates experienced complex operators from everyone else.

Dr. Megaly's presentation addressed the clinical framework he uses to make that call.

The Core Clinical Framework

High-risk PCI encompasses a wide spectrum. A patient with severely reduced ejection fraction, unprotected left main disease, or the last remaining conduit is not the same as a stable patient with a moderately complex lesion. MCS is not a reflexive decision; it's a calculated one.

The key variables Dr. Megaly applies:

Hemodynamic reserve

Ejection fraction alone is insufficient. He assesses the patient's ability to tolerate transient ischemia during balloon inflations or slow-flow events. A patient with EF of 25% and compensated hemodynamics is fundamentally different from one on the edge of cardiogenic shock.

Coronary anatomy and procedural complexity 

Unprotected left main, last remaining vessel, bifurcation disease requiring a two-stent strategy, or CTO PCI in a patient with limited collateral reserve all raise the MCS threshold.

Surgical turndown status 

Patients deemed too high-risk for bypass surgery who present to his lab require a different risk calculus entirely. These are the cases where prophylactic mechanical circulatory support is most defensible.

Operator experience and team readiness

MCS is only as effective as the team deploying it. An experienced operator should operate with a dedicated complex PCI infrastructure precisely so that MCS can be activated efficiently when the situation demands it.

What Being Invited to CRT Means for Oklahoma Patients

CRT faculty are selected based on peer recognition, publication record, and demonstrated technical expertise. Dr. Megaly's inclusion reflects his standing in the national conversation on complex PCI.

For patients in Oklahoma and the surrounding region, that translates directly: when your cardiologist says your case is too complex, or that surgery is your only option, a second opinion may open a path forward.

Dr. Michael Megaly specializes in complex and high-risk coronary interventions, chronic total occlusion (CTO) PCI, surgical turn-downs, complex peripheral artery disease, and limb salvage at Integris Health Heart Hospital in Oklahoma City.